Aquestive Therapeutics (AQST) Financials

$5.38

$0.14 (2.67%)

As on 02-Sep-2026 16:00EDT

Market cap

$630 Mln

Revenue (TTM)

$54 Mln

P/E Ratio

--

P/B Ratio

14.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	54.09	44.55	57.56	50.58	47.68	50.83
Cost of Revenue	17.83	17.15	17.87	20.83	19.39	14.99
Gross Profit	36.26	27.39	39.69	29.75	28.29	35.84
Operating Expenses	89.00	97.04	70.46	44.85	70.36	70.52
Operating Profit (EBIT)	-52.75	-69.65	-30.77	-15.10	-42.07	-34.68
Other Income	--	--	--	--	--	-13.40
Profit before Tax	-78.23	-83.78	-44.15	-7.63	-54.41	-70.54
Provision for Tax	--	--	-0.01	0.25	5.79	19.50
Profit after Tax (Net Income)	-78.23	-83.78	-44.14	-7.87	-54.41	-70.54
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-54.41	-70.54

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-56.59	-33.66	-60.16	-106.49	-118.55	-82.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	172.21	146.48	142.72	145.60	136.10	122.16
Current Liabilities	16.48	47.61	18.87	18.31	39.53	21.96
Total Liabilities	148.58	160.43	101.42	57.42	57.07	61.99

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	13.61	11.16	13.20	16.45	17.18	14.73
Current Assets	118.49	149.27	88.22	40.97	39.89	47.26
Total Assets	250.60	160.43	101.42	57.42	57.07	61.99
Total Debt*	59.00	131.45	38.00	33.32	57.49	56.42
Net Current Assets	--	101.66	69.36	22.66	0.21	25.30

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-52.43	-35.76	-6.38	-9.79	-32.98
Cash Flow from Investing Activities	--	-0.56	-0.16	-1.00	-2.52	-0.91
Cash from Financing Activities	--	102.62	83.59	3.97	11.56	30.11
Net Cash Inflow / Outflow	--	--	--	--	--	-3.78

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.65	-0.69	-0.48	-0.11	-1.00	-1.75
Cash EPS ($)	--	-0.68	-0.48	-0.10	-0.96	-1.67
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.43	-0.39	-0.09	-0.18	-0.82
Free Cash Flow per Share ($)	--	-0.43	-0.39	-0.11	-0.23	-0.84

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-221.56	92.61	11.73	125.40	418.23
ROE (%)	--	178.61	52.97	6.99	54.22	108.00
ROA (%)	-42.58	-63.99	-55.57	-13.75	-91.40	-112.97
EBIT Margin (%)	-114.45	-149.70	-47.49	-0.32	-88.02	-94.58
Net Margin (%)	-144.63	-188.09	-76.68	-15.56	-114.11	-188.44
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	22.56	-0.23	0.14	0.06	-0.06	0.11
EBIT Growth (%)	-28.75	-143.96	-16,669.33	99.61	12.71	-12.43
Net Profit Growth (%)	-20.27	-89.83	-460.83	85.54	22.87	-26.45
EPS Growth (%)	5.85	-0.42	-3.21	0.89	0.43	-0.06
Book Value Growth (%)	38.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-9.40	-7.36	-17.59	-0.90	-2.23
Price / Book Value	14.15	-23.41	-5.40	-1.30	-0.41	-1.91
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.81	-12.07	-10.94	125.11	-2.00	-4.11
Close Price ($)	4.16	6.46	3.56	2.02	0.90	3.89
High Price ($)	7.55	7.55	6.23	2.69	4.29	7.00
Low Price ($)	2.93	2.12	1.95	0.72	0.62	3.10
Market Cap ($ Cr)	630.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-3.90	-0.63	-0.31	-0.48	-0.69
Short term debt to equity ratio	-0.01	-0.35	-0.01	0.00	-0.16	-0.04
Current Ratio	7.19	3.14	4.68	2.24	1.01	2.15
Quick Ratio	6.74	3.01	4.36	1.87	0.86	1.97
Interest Coverage	-3.79	-3.90	-1.63	-0.02	-3.37	-2.14

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	17.24	39.88	12.76	16.75	9.87	23.84
Asset Turnover	0.29	0.34	0.72	0.88	0.80	0.81
Receivable days	--	102.93	50.18	47.57	64.44	68.53
Inventory Days	--	130.02	130.93	110.02	92.49	79.18
Payable days	--	427.43	196.33	165.45	172.02	187.67
Cash Conversion Cycle	--	-194.47	-15.22	-7.87	-15.09	-39.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.